New Results
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry
Febe van Maldegem, Karishma Valand, Megan Cole, Harshil Patel, Mihaela Angelova, Sareena Rana, Emma Colliver, Katey Enfield, Nourdine Bah, Gavin Kelly, Victoria Siu Kwan Tsang, Edurne Mugarza, Christopher Moore, Philip Hobson, Dina Levi, Miriam Molina-Arcas, Charles Swanton, View ORCID ProfileJulian Downward
doi: https://doi.org/10.1101/2021.02.02.429358
Febe van Maldegem
1Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
7Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUMC, De Boelelaan 1108, 1081HZ Amsterdam, The Netherlands
Karishma Valand
1Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Megan Cole
1Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Harshil Patel
2Bioinformatics and Biostatistics Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Mihaela Angelova
3Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Sareena Rana
1Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
4Lung Cancer Group, Division of Molecular Pathology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK
Emma Colliver
3Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Katey Enfield
3Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Nourdine Bah
2Bioinformatics and Biostatistics Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Gavin Kelly
2Bioinformatics and Biostatistics Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Victoria Siu Kwan Tsang
1Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Edurne Mugarza
1Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Christopher Moore
1Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Philip Hobson
5Flow Cytometry Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Dina Levi
5Flow Cytometry Science Technology Platform, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Miriam Molina-Arcas
1Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
Charles Swanton
3Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
6Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O’Gorman Building, 72 Huntley Street, London WC1E 6DD, UK
Julian Downward
1Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
4Lung Cancer Group, Division of Molecular Pathology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK
Posted September 21, 2021.
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry
Febe van Maldegem, Karishma Valand, Megan Cole, Harshil Patel, Mihaela Angelova, Sareena Rana, Emma Colliver, Katey Enfield, Nourdine Bah, Gavin Kelly, Victoria Siu Kwan Tsang, Edurne Mugarza, Christopher Moore, Philip Hobson, Dina Levi, Miriam Molina-Arcas, Charles Swanton, Julian Downward
bioRxiv 2021.02.02.429358; doi: https://doi.org/10.1101/2021.02.02.429358
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry
Febe van Maldegem, Karishma Valand, Megan Cole, Harshil Patel, Mihaela Angelova, Sareena Rana, Emma Colliver, Katey Enfield, Nourdine Bah, Gavin Kelly, Victoria Siu Kwan Tsang, Edurne Mugarza, Christopher Moore, Philip Hobson, Dina Levi, Miriam Molina-Arcas, Charles Swanton, Julian Downward
bioRxiv 2021.02.02.429358; doi: https://doi.org/10.1101/2021.02.02.429358
Subject Area
Subject Areas
- Biochemistry (11703)
- Bioengineering (8718)
- Bioinformatics (29127)
- Biophysics (14930)
- Cancer Biology (12048)
- Cell Biology (17353)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14143)
- Epidemiology (2067)
- Evolutionary Biology (18266)
- Genetics (12219)
- Genomics (16765)
- Immunology (11841)
- Microbiology (28003)
- Molecular Biology (11551)
- Neuroscience (60804)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3229)
- Physiology (4939)
- Plant Biology (10383)
- Synthetic Biology (2877)
- Systems Biology (7333)
- Zoology (1642)